1Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002,2(7 ) :395-403
2Marigold CMT, Unckell F, Werr M, et al. Analysis of intermolecular disulfide bonds and flee sulfhydryl groups in hepatitis B surface antigen particles. Arch Viral, 1997,142( 11 ) :2257-2267
3Gavilanes F, Gonzalez-ros JM, Peterson DL. Structure of hepatitis B surface antigen. J Biol Chem, 1982,257 ( 13 ) :7770-7777
4Peterson DL,Paul DA, Lain J,et al. Antigenic structure of hepatitis B surface antigen : identification of the ‘d' subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol, 1984 ; 132 (2) :920-927
5Marigold CM, Unckell F, Werr M, et al. Secretion and antigenicity of hepatitis B virus small envelope protoins lacking cysteines in the major antigenic region. Virology, 1995,211 (2) :535-543
6Palmer DR,Perry KR.,Mortimer PP,et al. Variation in the sensitivity of HBsAg screening kits. Transfus Med,1996,6(4) :311-317
7Zaaijer HL, Vrielink H, Kcot M. Early detection of hepatitis B surface antigen and detection of HBsAg mutants: A comparison of five assays. Vox Sang,2001,81 (4) :217-221
8Suslov AP, Kuzin SN, Sadikova NV, et al. Performance of ELISA HBsAg test kits with use of different types of panels containing HBsAg. Russ J Immunol,2000,5 (2) :217-226
9Grab P,Jilg WG, Bomhak H, et al. Serological pattern 'anti-HBc alone' :Report on a workshop. J Med Virol,2000,62(4) :450-455
10Gerlich WH. Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. Intercirology, 2004,47 (6) :310-313
3Taylor P, Pickard G, Gananie A, et al. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory. J Clin Viral, 2004, 30 ( Suppl 1 ) :S11-15.
4Chen D, Kaplan LA. Performance of a new-generation chemiluminescent assay for hepatitis B surface antigen. Clin Chem,2006,52:1592-1598.
5Palmer DR, Perry KR, Mortimer PP, et al. Variation in the sensitivity of HBsAg screening kits. Transfus Med, 1996,6 : 311 - 317.
6Saldanha J, Lelie N, Heath A. Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNA. Vox Sanguinis, 1999,76:149- 158.
7Ferguson M, Pipkin PA, Heath AB, et al. Working standards for hepatitis B surface antigen for use in the UK Blood Transfusion Service: results of a collaborative study. Vox Sang,1993,65:303- 308.
